Who we are

Founded in 2017, Coral Health is a technology company that is building a more connected future in healthcare. We develop blockchain-powered solutions that accelerate care delivery, automate multiparty administrative processes, and improve health outcomes by enabling secure, real-time, shared access to validated healthcare information.



Philip Parker

Philip Parker

Co-Founder & Chief Operating Officer

Philip Parker is a data scientist with expertise leveraging diverse data assets to guide operations and marketing strategy. After graduating from Harvard University, Philip consulted for Fortune 500 pharmaceutical clients at Analysis Group, where he led health economics and effectiveness projects across a range of treatments. He then worked to drive the financial and clinical performance of health systems at athenahealth, a top US electronic medical record and revenue cycle management company. Philip’s previous projects have also included partnerships with public health agencies, national foundations, and top academics.

Andy Park

Andy Park

Co-Founder & Chief Innovation Officer

Andy Park is a health technology entrepreneur who has developed patent-pending software tools currently used by Genentech, Bristol-Myers Squibb, Johnson & Johnson and others. He founded Coral Health, a natural extension of his PhD thesis research, after realizing the power of the blockchain to solve key security and data aggregation issues in the medical industry. He has assembled a growing team of Harvard-educated technologists, globally relevant scientists, and key health policy experts. Coral Health will be a centerpiece for the future of testing methodologies, genomics data protocols, secure health technologies, and real-time patient access platforms.

Steven Noble

Steven Noble

Sales

Steven Noble is a capital fundraiser, with previous focus on capitalizing junior securities. Steven is CSC certified from Canadian Securities Insititute. Steven has a background in emerging technologies previously working in the Drone and Virtual Reality Industries.

Kriston Costa

Kriston Costa

Sr. Software Engineer
Jeremy Mullin

Jeremy Mullin

Co-Founder & Chief Strategy Officer

Jeremy Mullin is a strategist and data expert who advised Fortune 1000 enterprises on digital data collection. He served as a Director at Research Now, Inc., is a Board Director for the Toronto chapter of the Marketing Research and Intelligence Association (MRIA) and is a member of the Data Science Association. Mr. Mullin leads Coral Health's corporate partnership and collaboration strategies.

Allan Mah

Allan Mah

Chief Scientific Officer

Allan Mah is a life science professional who obtained his PhD from Simon Fraser University. His research centered on identifying genetic pathways, which are involved in the development and function of key organ systems. After completing postdoctoral research focused on elucidating metabolic gene regulatory networks, Dr. Mah entered the biotech industry, where he uses data-driven approaches to develop product and partnership strategies.

Noor Manji

Noor Manji

Marketing Manager

Noor Manji is Coral Health's Marketing and Community Manager. With diverse experience within the technology and software industries, Noor has successfully executed multi-channel campaigns across consumer and enterprise markets. At Coral Health, Noor is responsible for leading the marketing strategy and brand development, and manages Coral's fast growing social and digital communities. Prior to joining Coral Health, Noor was an integral member of the team that commercially launched WIND Mobile in Canada.

John Dengis

John Dengis

Sr. Software Engineer
Nikola Grcevski

Nikola Grcevski

Chief Technology Officer

Nikola Grcevski draws upon years of deep technical expertise gained while working in various engineering and leadership positions at IBM. As part of the compiler and runtime technology group, he worked directly with numerous Fortune 500 companies in the financial and online retail industries, helping them achieve scale and drive forward their application performance. Nikola led a team in Toronto and Shanghai focused on Java runtime optimization for the Intel architecture, directing the product performance and shaping future middleware offerings. Nikola has filed thirteen software patents, and has been awarded a high value patent award for his work on runtime memory optimization.

Luke Cyca

Luke Cyca

Architect

Luke Cyca is the Systems Architect at Coral Health. Luke served as Senior Systems Architect at Zymeworks Inc., a computational pharmaceutical company developing antibody and protein therapeutics. At Zymeworks, Luke was the lead developer of a Laboratory Information Management System (LIMS) used to manage protein sequence information.

Sahar Ebrahimi

Sahar Ebrahimi

Sr. Software Engineer



Advisory group


Don Tapscott

Don Tapscott

Don is frequently cited as one of the most influential and authoritative individuals in the blockchain world. He is the Co-founder and Executive Chairman at The Blockchain Research Institute and best selling co-author of Blockchain Revolution.

Stephen Galebach

Stephen Galebach

Stephen Galebach has extensive corporate experience as a legal generalist and served in the United States Department of Justice during the Ronald Reagan Administration. In 2000, he was the IPO Manager for Genuity, who completed the largest Internet IPO in U.S. history at the time. He is a U.S. based lawyer, admitted in Massachusetts and the District of Columbia and received his J.D., magna cum laude, from Harvard Law School.

Dr. Thiago Bassi

Dr. Thiago Bassi

Dr. Thiago Bassi, MD, is a neurosurgeon who graduated in the top 3 of his class at Faculdade de medicina de catanduva in Brazil. He practiced in a large range of neurosurgery specialties including trauma surgery, spinal surgery, vascular surgery and functional surgery. He now lends his expertise to the intersection of research and medicine in academic and clinical settings. He advises Coral Health in product design, client communication and pilot project execution.

Marco Gallo

Marco Gallo

Marco Gallo is the director of the Gallo Lab, where he studies epigenomes of pediatric and adult brain tumors. His current studies build on his discovery that chromatin architecture specifies cell behavior - including the key cancer property known as ‘self-renewal’ - which is considered the root cause of tumor recurrence. Dr. Gallo currently serves as Assistant Professor of Biochemistry at University of Calgary; he holds a PhD in Biochemistry and Molecular Biology. He is a paid advisor to Coral Health and contributes scientific and academic expertise.

Michael Chin

Michael Chin

Michael is a Co-Founder of Blockmason, which has executed a successful Token Sale with BCPT and is listed on various cryptocurrency exchanges. After growing up in Seattle, Michael graduated magna cum laude from Washington University in St. Louis with degrees in finance and accounting. He joined J.P. Morgan in their New York and Hong Kong practice for credit transactions - primarily in principal mezzanine and subordinated debt investments as well as syndicated leveraged finance and high yield capital markets. In this capacity, Michael’s teams executed more than US$1 billion of transactions globally. He later joined Intermediate Capital Group (a FTSE 250 composite company with over Euro$20 billion in AUM) and subsequently served as Managing Director of Constance Capital originating and executing share-backed financing loans. Michael is fluent in Mandarin, is an investor in technology and property, and currently lives in Hong Kong.